ID: PMRREP32254| Upcoming | Format: PDF, Excel, PPT* | Healthcare
The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system. According to the National Institute of Environment Health Sciences, over 9.3 million individual in U.S. are predicted to be affected with Parkinson’s disease by 2020. Nerve growth factor regulates the growth of the nerve that regulates the sensation of touch, heat and pain.
The elevated level of nerve growth factor is causing inflammatory diseases, multiple sclerosis and psychiatric disorders. The nerve growth factor is of several types such as beta-nerve growth factor, HSAN5, NGFB, NGF_HUMAN and others. The nerve growth factor is also associated with type 2 diabetes, obesity, coronary atherosclerosis and other metabolic syndromes.
Nerve growth factor also affects the inflammation of the endometrium. The global nerve growth factor market is expected to grow due to the rising prevalence of brain-related complications, expanding geriatric population and advancing neuroscience therapy and research.
The research finding indicating the impact of several growth factors including nerve growth factor on COVID-19 are expected to impact the overall growth of the global nerve growth factor amid the coronavirus pandemic. Since viruses are impacted the growth factors and the tyrosine kinase signaling for their replication. The increasing investment in research for the study of nerve growth factor, its inhibition and interaction with the COVID-19 can shape the repurposing drugs developments.
Surging prevalence of neurological diseases, growing geriatric populations and the advancing therapies for the vast spectrum of neurological diseases, injuries and others are expected to drive the growth of the global nerve growth factor market.
The growing population of the aged population, increasing awareness of neurological disorders such as dementia, amnesia, depressions, etc. induced by the stressful lifestyle are fueling the market growth. The research on the blocking molecules of nerve growth factors for the therapy of several diseases ranging from viral infections, gynecological complications to Alzheimer is pushing the investments into this market.
However, the strict regulatory rules, high healthcare expenditure and expensive clinical trials are decelerating the market growth. Although, the research and therapeutic progress of nerve growth factor for the nerve cell recovery to treat the nerve damages caused after chemical exposure, surgeries and is ischemia are expected to support the overall market growth.
| By indication |
|
| By type |
|
The global nerve growth factor market is expected to leverage further in future due to increasing cases of neurological complications and progressing research and clinical advancements of the nerve growth factor certain therapies. By indication, the market is segmented into peripheral neuropathies, central neurodegenerative disease, autoimmune diseases and others.
The nerve growth factor is being utilized for regenerative therapies for neurological diseases, neuron damages and others. It has been observed to be well tolerated for eye drops administration. By type, the nerve growth factor divided into KP-544, MT-2, 8 and MEDI-7352.
North America and Europe are expected to rule the global nerve growth factor market due to their huge prevalence and incidence of neurodegenerative diseases. Europe is burdened with brain diseases which account for 35% of the total diseases.
The growing awareness and escalating research and clinical progress are expected to further push the nerve growth factor market in North America and Europe. The Asia-Pacific nerve growth factor is expected to grow at a fast pace, driven by the emerging therapies, massive patient base and increasing awareness of brain diseases.
Latin America nerve growth factor market is expected to leverage at a gradual pace with its progressing research and healthcare infrastructure and growing awareness.
The Middle East & Africa nerve growth factor market is expected to grow at stagnant pace owing to its rickety healthcare and research infrastructure and a dearth of awareness.
The key players of global nerve growth factor market include Eli Lilly & Company, Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories, Inc., Sanofi, Regeneron Pharmaceuticals, Inc., Enzo Life Sciences, Inc., Astellas Pharma Inc. and others.
Delivery Timelines
For more information on this report and its delivery timelines please get in touch with our sales team.
